Anhydrous composition for topical use in the form of a dispersed phase based on at least one short glycol in a continuous fatty phase
By using gelling phase composed of specific glycols and emulsified surfactants in water-in-oil emulsions, the volatile and sensory properties of silicone derivatives in existing water-in-oil emulsions are solved, and a long time is achieved at ambient temperature Dermatological lotions that maintain uniformity and stability reduce the risk of preservative use and microbial proliferation, providing long-lasting skin protection.
Patent Information
- Application Number
- CN202080056031.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-08-09
- Filing Date
- 2020-08-04
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2040-08-04
AI Technical Summary
The silicone derivatives used in existing dermatological emulsions in water-in-oil form have volatile and unpleasant sensory properties and are difficult to maintain uniformity and stability for a long time at ambient temperature, especially during storage and use. During the process.
A composition was developed that contains a gelled phase without added water and an oily continuous phase consisting of specific glycols and emulsified surfactants with a dynamic viscosity greater than 1000 mPa.s and less than 100,000 at 20°C. mPa.s, used in local applications, ensures uniformity and stability for a long time at ambient temperature.
The composition maintains uniformity and stability for at least three months in the range of 20°C to 45°C, avoiding separation of the aqueous dispersed phase, reducing the risk of microbial proliferation, and reducing the use of preservatives, providing long-lasting skin protection effect.
Smart Images

Figure BDA0003495047880000061 
Figure BDA0003495047880000062 
Figure BDA0003495047880000101
Abstract
Description
[0001] The present invention provides novel compositions in the form of dispersions of a gel phase comprising at least one diol consisting of three to eight carbon atoms in an oil phase, and also their use in cosmetics, medicine, the textile industry and the paper industry.
[0002] The cosmetic, dermocosmetic, dermopharmaceutical and pharmaceutical compositions may be in the form of aqueous solutions, emulsions and powders.
[0003] An emulsion is an initially heterogeneous mixture of two mutually immiscible liquid substances, which are called "phases". The mixture is rendered macroscopically homogeneous by external manipulations such as mechanical stirring with appropriate speed and movement, or the addition of amphiphilic substances called surfactants. When presented in a macroscopically homogeneous form, the mixture consists of a discontinuous phase dispersed in another phase called the "continuous phase".
[0004] Emulsions are a particularly preferred form, since they can deliver both water-soluble and fat-soluble substances, which are often used in these applications. A distinction is made between oil-in-water (O / W) emulsions, in which the continuous phase consists of a hydrophilic phase (usually an aqueous phase) and the dispersed phase consists of a lipophilic fatty phase, and water-in-oil (W / O) emulsions, in which the continuous phase consists of a lipophilic fatty phase and the dispersed phase consists of a hydrophilic phase (usually an aqueous phase), and water-in-oil emulsions, in which the continuous phase consists of a lipophilic fatty phase and the dispersed phase consists of a hydrophilic phase (usually an aqueous phase).
[0005] Oil-in-water emulsions are inherently more stable than water-in-oil emulsions; however, water-in-oil emulsions have many advantages. Specifically, the separation between water droplets reduces the possibility of microbial proliferation. In addition, when the continuous phase is an aqueous phase, the use of preservatives is essential, and when the continuous phase is a fat phase, the use of preservatives can be avoided or reduced. Water-in-oil emulsions are far less sensitive to low temperatures than oil-in-water emulsions. Finally, for topical applications of cosmetic uses, a European patent application published under number EP 1961455 A1 discloses that an oily continuous phase can cover the skin after applying a water-in-oil emulsion, which protects the skin from dehydration and against external substances by forming a persistent oil film, thereby treating dry skin.
[0006] The solutions proposed in the prior art for preparing dermatological emulsions in water-in-oil form are unsatisfactory because the silicone derivatives used are either volatile and can have harmful effects on the environment and the user, or are not very volatile and then impart unpleasant sensory properties after topical application, such as, for example, a sticky feeling on the skin.
[0007] The European patent application published under the number EP 1 459 801 A2 and the international patent application published under the number WO 2014 / 167200 A1 disclose the preparation of water-in-oil emulsions containing, per 100% of their weight, from 60% to 98% by weight of an aqueous phase gelled by the presence of crosslinked polyelectrolytes therein, making it possible to partially solve this technical problem. In fact, the water-in-oil emulsions obtained are characterized by having a better persistence when applied to the skin, making it possible to withstand sweat, bath water or rain. However, in a continuous improvement, research is being conducted on formulations in galenic form that are even more resistant to water and sweat, also making it possible to deliver several cosmetic or pharmaceutical active ingredients that are partially insoluble or unstable in aqueous media.
[0008] This is why the inventors have attempted to develop new emulsions in which the continuous phase is oily and the dispersed phase is polar but non-aqueous, containing no added water, which do not exhibit the above-mentioned disadvantages and which remain homogeneous at ambient temperature (greater than or equal to 20° C. and less than or equal to 25° C.) and at 45° C. after storage for at least three months.
[0009] The solution of the invention is a composition for topical use (E1) comprising a gelled phase (A1) free of added water and dispersed in a continuous phase (A2), wherein:
[0010] the gel phase (A1) comprises at least one diol selected from 1,2-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 2,3-butylene glycol, 2,3-pentanediol, 2,3-hexanediol, 2,5-hexanediol or 2-methyl-2,4-pentanediol, and
[0011] The fatty phase (A2) comprises at least one oil, at least one emulsifying surfactant (S1) and at least one emulsifying surfactant (S2).
[0012] Preferably, the composition (E1) comprises, per 100% by weight:
[0013] from 60 to 98% by weight, preferably from 60 to 95% by weight and even more preferably from 60 to 90% by weight of a gelled phase (A1), and
[0014] - from 2 to 40% by weight, preferably from 5 to 40% by weight and even more preferably from 10 to 40% by weight of a fatty phase (A2).
[0015] The emulsifying surfactant (S1) is preferably selected from the group consisting of an alkyl polyglycoside composition and a composition of an alkyl polyglycoside and a fatty alcohol, and the emulsifying surfactant (S2) is preferably selected from the group consisting of polyglycerol esters, alkoxylated polyglycerol esters, polyglycol polyhydroxystearate, polyglycerol polyhydroxystearate and alkoxylated polyglycerol polyhydroxystearate.
[0016] The expression "for topical use" used in the definition of the composition (E1) according to the invention in the form of a dispersion of a gelled phase (A1) in a continuous phase (A2) and as defined above means that the composition (E1) is used by application to the skin, the hair, the scalp or the lips, whether it is direct application in the case of a cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical composition, or indirect application, for example in the case of a body hygiene product in the form of a textile or paper wipe or a health product intended to come into contact with the skin or the lips.
[0017] For the purposes of the present invention, the term "gel phase (A1)" indicates a homogeneous phase, characterized in that the dynamic viscosity of said phase (A1) (measured at a temperature of 20° C. and at a speed of 6 rpm using a Brookfield LVT viscometer) is greater than or equal to 1000 mPa.s and less than or equal to 100 000 mPa.s, more particularly greater than or equal to 10 000 mPa.s and less than or equal to 100 000 mPa.s.
[0018] The composition according to the invention may exhibit one or more of the following characteristics, as the case may be:
[0019] - The gel phase (A1) contains, per 100% of its weight, from 0.5% to 10% by weight of a crosslinked anionic polyelectrolyte (AP1) and from 90% to 99.5% by weight of at least one diol chosen from the following: 1,2-propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 2,3-butanediol, 2,3-pentanediol, 2,3-hexanediol, 2,5-hexanediol or 2-methyl-2,4-pentanediol. It should be noted that preferably, the gel phase (A1) comprises, per 100% of its weight, from 0.5% to 8.5% by weight, more preferably from 0.5% to 7% by weight, of a crosslinked anionic polyelectrolyte (AP1) and from 91.5% to 99.5% by weight, more particularly from 93% to 99.5% by weight, of at least one diol chosen from 1,2-propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 2,3-butanediol, 2,3-pentanediol, 2,3-hexanediol, 2,5-hexanediol or 2-methyl-2,4-pentanediol;
[0020] - the diol is selected from 1,2-propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,2-pentanediol, 1,2-hexanediol or 2-methyl-2,4-pentanediol;
[0021] the crosslinked anionic polyelectrolyte (AP1) comprises a proportion greater than or equal to 25 mol % of monomer units derived from 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid in free acid or partially or completely salified form;
[0022] - The emulsifying surfactant (S1) is composed of at least one alkyl polyglycoside composition (C1) represented by formula (VII):
[0023] R1-O-(G)xH (VII)
[0024] wherein x represents a decimal between 1.05 and 2.5, G represents a glucosyl group or an α,β-D-glucopyranose group obtained by removing a hemiacetal hydroxyl group from α,β-D-glucopyranose, and R1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, the composition (C1) consisting of a mixture of compounds represented by formulae (VII1), (VII2), (VII3), (VII4) and (VII5):
[0025] R1-O-(G)1-H(VII1)
[0026] R1-O-(G)2-H(VII2)
[0027] R1-O-(G)3-H(VII3)
[0028] R1-O-(G)4-H(VII4)
[0029] R1-O-(G)5-H(VII5),
[0030] These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5, such that the sum of a1+a2+a3+a4+a5 is equal to 1 and such that the sum of a1+2a2+3a3+4a4+5a5 is equal to x;
[0031] The emulsifying surfactant (S1) consists of at least one composition (C2) comprising, per 100% by weight:
[0032] From 10% to 50% by weight of at least one alkyl polyglycoside composition (C1) represented by formula (VII):
[0033] R1-O-(G)xH (VII),
[0034] wherein x represents a decimal between 1.05 and 2.5, G represents a glucosyl group or an α,β-D-glucopyranose group obtained by removing a hemiacetal hydroxyl group from α,β-D-glucopyranose, and R1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, the composition consisting of a mixture of compounds represented by formulae (VII1), (VII2), (VII3), (VII4) and (VII5):
[0035] R1-O-(G)1-H (VII1)
[0036] R1-O-(G)2-H (VII2)
[0037] R1-O-(G)3-H (VII3)
[0038] R1-O-(G)4-H (VII4)
[0039] R1-O-(G)5-H (VII5)
[0040] These compounds are in corresponding molar proportions a1, a2, a3, a4 and a5, such that the sum of a1+a2+a3+a4+a5 is equal to 1 and such that the sum of a1+2a2+3a3+4a4+5a5 is equal to x; and
[0041] From 90 to 50% by weight of at least one fatty alcohol of formula (VIII):
[0042] R”1-OH (VIII),
[0043] wherein R"1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, wherein R"1 may be the same as or different from R1;
[0044] - The emulsifying surfactant (S1) is composed of at least one alkyl polyglycoside composition (C'1) represented by formula (IX):
[0045] R1-O-(G) x -H(IX)
[0046] wherein x represents a decimal between 1.05 and 2.5, G represents a xylose residue, and R1 represents 2-octyldodecyl, the composition (C'1) consisting of a mixture of compounds represented by formula (IX1), (IX2), (IX3), (IX4) and (IX5):
[0047] R1-O-(G)1-H(IX1)
[0048] R1-O-(G)2-H(IX2)
[0049] R1-O-(G)3-H(IX3)
[0050] R1-O-(G)4-H(IX4)
[0051] R1-O-(G)5-H(IX5)
[0052] These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5, such that the sum of a1+a2+a3+a4+a5 is equal to 1 and such that the sum of a1+2a2+3a3+4a4+5a5 is equal to x;
[0053] - the emulsifying system (S) consists of a composition (C'2) which comprises, per 100% by weight:
[0054] From 10% to 50% by weight of at least one alkyl polyglycoside composition (C'1) represented by formula (X):
[0055] R1-O-(G) x -H (X)
[0056] wherein x represents a decimal between 1.05 and 2.5, G represents a xylose residue, and R1 represents 2-octyldodecyl, the composition consisting of a mixture of compounds represented by formula (X1), (X2), (X3), (X4) and (X5):
[0057] R1-O-(G)1-H (X1)
[0058] R1-O-(G)2-H (X2)
[0059] R1-O-(G)3-H (X3)
[0060] R1-O-(G)4-H (X4)
[0061] R1-O-(G)5-H (X5)
[0062] These compounds are in corresponding molar proportions a1, a2, a3, a4 and a5, such that the sum of a1+a2+a3+a4+a5 is equal to 1 and such that the sum of a1+2a2+3a3+4a4+5a5 is equal to x; and
[0063] From 90 to 50% by weight of at least one fatty alcohol of formula (XI):
[0064] R''1-OH (XI),
[0065] Wherein R"'1 represents 2-octyldodecyl;
[0066] - The emulsifying surfactant (S2) consists of at least one polyglycol polyhydroxystearate represented by formula (XII):
[0067] [Chemical formula 1]
[0068]
[0069] wherein y2 represents an integer greater than or equal to 2 and less than or equal to 50, R4 represents a hydrogen atom, a methyl group or an ethyl group, and Z2 represents a group having the formula (XIII):
[0070] [Chemical formula 2]
[0071]
[0072] wherein y'2 represents an integer greater than or equal to 0 and less than or equal to 10, more particularly greater than or equal to 1 and less than or equal to 10, and Z'2 represents: a group of formula (XIII) as defined above, wherein Z'2 may be identical to or different from Z2; or a hydrogen atom;
[0073] - the composition for topical use (E1) comprises one or more auxiliary compounds chosen from the following: foaming and / or detergent surfactants, thickening and / or gelling surfactants, thickeners and / or gelling agents, stabilizers, film-forming compounds, solvents and cosolvents, hydrotropes, plasticizers, emulsifiers and coemulsifiers, opacifiers, self-tanning agents, pearlescent agents, superfatting agents, sequestrants, chelating agents, antioxidants, fragrances, essential oils, preservatives, conditioners, deodorants, bleaching agents intended for bleaching body hair and skin, active ingredients intended to provide treatment and / or protection for the skin or hair, sunscreens, mineral fillers or pigments, particles giving visual effects or intended for encapsulating active agents, exfoliating particles, texturizing agents, optical whitening agents and insect repellents. In general, the composition for topical use (E1) according to the invention may contain excipients and / or active ingredients commonly used in the field of formulations for topical use, in particular for cosmetic, dermocosmetic, pharmaceutical or dermopharmaceutical use;
[0074] - said composition contains, per 100% of its weight, one or more self-tanning agents in a proportion between 0.5% by weight and 10% by weight. Preferably, said self-tanning agent will be chosen from elements of the group consisting of dihydroxyacetone, erythrulose, glyceraldehyde, isatin, alloxan, ninhydrin and mesotartaric acid aldehyde, and preferably from dihydroxyacetone and erythrulose. Thus, said composition comprising a self-tanning agent will preferably be used for artificial tanning and / or neandering of the skin, and a subject of the present invention will also be a cosmetic treatment method for artificial tanning and / or neandering of the skin, comprising at least one step of applying the above composition (E1) to said human skin.
[0075] A subject of the present invention is also the use of a composition (E1) as defined above for the cosmetic treatment of the skin, the hair, the scalp and / or the lips.
[0076] Preferably, said composition (E1) will be a composition for cleansing, protecting or caring for the skin, hair, scalp or lips.
[0077] Preferably, the fatty phase (A2) comprises, per 100% of its weight:
[0078] - from 1.25% to 25% by weight, more particularly from 1.25% to 20% by weight, of an emulsifying system (S), comprising per 100% by weight of said emulsifying system (S):
[0079] from 12% to 88% by weight, more particularly from 15% to 85% by weight, and still more particularly from 20% by weight to 85% by weight of at least one emulsifying surfactant (S1), and
[0080] from 12 to 88% by weight, more particularly from 15 to 85% by weight, and still more particularly from 20% by weight to 85% by weight of at least one emulsifying surfactant (S2);
[0081] - from 75% to 98.75% by weight, more particularly from 80% to 98.75% by weight and more particularly still from 82% to 98.75% by weight of at least one oil and optionally at least one wax.
[0082] The term "oil" means a compound and / or mixture of compounds that is insoluble in water and liquid at 25° C., and more particularly:
[0083] - straight-chain alkanes containing from 11 to 19 carbon atoms;
[0084] - branched alkanes containing from 7 to 40 carbon atoms, such as isododecane, isopentadecane, isohexadecane, isoheptadecane, isooctadecane, isononadecane or isoeicosane, or mixtures of some of them, such as those mentioned below and identified by their INCI names: C 7-8 Isoparaffin, C 8-9 Isoparaffin, C 9-11 Isoparaffin, C 9-12 Isoparaffin, C 9-13 Isoparaffin, C 9-14 Isoparaffin, C 9-16 Isoparaffin, C 10-11 Isoparaffin, C 10-12 Isoparaffin, C 10-13 Isoparaffin, C 11-12 Isoparaffin, C 11-13 Isoparaffin, C 11-14 Isoparaffin, C 12-14 Isoparaffin, C 12-20 Isoparaffin, C 13-14 Isoparaffin, C 13-16 Isoparaffins;
[0085] - Cycloalkanes optionally substituted by one or more linear or branched alkyl groups;
[0086] - white mineral oils such as those sold under the name: Marcol TM 52. Marcol TM 82. Drakeol TM 6VR, Eolane TM 130. Eolane TM 150;
[0087] - Hemi-squalane (or 2,6,10-trimethyldodecane; CAS No.: 3891-98-3), squalane (or 2,6,10,15,19,23-hexamethyltetracosane), hydrogenated polyisobutylene or hydrogenated polydecene;
[0088] - mixtures containing alkanes having from 15 to 19 carbon atoms, said alkanes being linear, branched and cycloalkanes, and more particularly mixtures (M1) which, per 100% of their weight, contain a weight proportion of branched alkanes greater than or equal to 90% and less than or equal to 100%, a weight proportion of linear alkanes greater than or equal to 0% and less than or equal to 9%, and more particularly less than 5%, and a weight proportion of cycloalkanes greater than or equal to 0% and less than or equal to 1%, for example under the name Emogreen TM L15 or Emogreen TM L19 Mixtures sold;
[0089] - Fatty alcohol ether of formula (II):
[0090] Z1-O-Z2 (II),
[0091] wherein Z1 and Z2 may be the same or different and represent a straight or branched chain alkyl group comprising from 5 to 18 carbon atoms, for example dioctyl ether, didecyl ether, dodecyl ether, dodecyl ether, dodecyl octyl ether, hexacosyl ether, (1,3-dimethylbutyl)tetradecyl ether, (1,3-dimethylbutyl)hexadecyl ether, bis(1,3-dimethylbutyl) ether or dihexyl ether.
[0092] - Monoesters of fatty acids and alcohols of formula (III):
[0093] R'1-(C=O)-O-R'2 (III),
[0094] wherein R'1-(C=O) represents a saturated or unsaturated, linear or branched acyl group containing from 8 to 24 carbon atoms, and R'2, independently of R'1, represents a saturated or unsaturated, linear or branched hydrocarbon-based chain containing from 1 to 24 carbon atoms, for example methyl laurate, ethyl laurate, propyl laurate, isopropyl laurate, butyl laurate, 2-butyl laurate, hexyl laurate, methyl cocoate, ethyl cocoate, propyl cocoate, isopropyl cocoate, butyl cocoate, 2-butyl cocoate, hexyl cocoate, methyl myristate, ethyl myristate, propyl myristate, isopropyl myristate, butyl myristate, 2-butyl myristate Esters, hexyl myristate, octyl myristate, methyl palmitate, ethyl palmitate, propyl palmitate, isopropyl palmitate, butyl palmitate, 2-butyl palmitate, hexyl palmitate, octyl palmitate, methyl oleate, ethyl oleate, propyl oleate, isopropyl oleate, butyl oleate, 2-butyl oleate, hexyl oleate, octyl oleate, methyl stearate, ethyl stearate, propyl stearate, isopropyl stearate, butyl stearate, 2-butyl stearate, hexyl stearate, octyl stearate, methyl isostearate, ethyl isostearate, propyl isostearate, isopropyl isostearate, butyl isostearate, 2-butyl isostearate, hexyl isostearate, isostearyl isostearate;
[0095] - Diesters of fatty acids of formula (IV) and formula (V) and glycerol:
[0096] R'3-(C=O)-O-CH2-CH(OH)-CH2-O-(C=O)-R'4 (IV)
[0097] R'5-(C=O)-O-CH2-CH[O-(C=O)-R'6]-CH2-OH (V),
[0098] Formulas (IV) and (V), wherein R'3-(C=O), R'4-(C=O), R'5-(C=O) and R'6-(C=O) may be the same or different and represent a saturated or unsaturated, linear or branched acyl group comprising from 8 to 24 carbon atoms;
[0099] - Triesters of fatty acids and glycerol of formula (VI):
[0100] R'7-(C=O)-O-CH2-CH[O-(C=O)-R”8]-CH2-O-(C=O)-R”9 (VI),
[0101] Wherein R'7-(C=O), R'8-(C=O) and R'9-(C=O) may be the same or different and represent a saturated or unsaturated, linear or branched acyl group comprising from 8 to 24 carbon atoms.
[0102] - vegetable oils, such as squalane, sweet almond oil, coconut oil, castor oil, jojoba oil, olive oil, rapeseed oil, peanut oil, sunflower oil, wheat germ oil, corn germ oil, soybean oil, cottonseed oil, alfalfa oil, poppy seed oil, pumpkin seed oil, evening primrose oil, millet oil, barley oil, rye oil, safflower oil, tung oil, passionflower oil, hazelnut oil, palm oil, shea butter, almond oil, sedge leaf oil, mustard seed oil, avocado oil, calendula oil, oils derived from flowers or vegetables;
[0103] -Ethoxylated vegetable oils.
[0104] Preferably, the composition according to the invention comprises at least one oil chosen from the elements of the group consisting of castor oil, liquid paraffin, cocoyl caprylate / caprate, isopropyl myristate and capric / caprylic triglyceride.
[0105] The fatty phase (A2) optionally comprises waxes. The latter are more particularly chosen from beeswax, carnauba wax, candelilla wax, carnauba wax, Japan wax, cork wax, sugar cane wax, paraffin wax, montan wax, microcrystalline wax, lanolin wax; ozokerite wax; polyethylene wax; silicone wax; vegetable wax; fatty alcohols and fatty acids that are solid at ambient temperature; glycerides that are solid at ambient temperature.
[0106] In the definition of the composition for topical use (E1) that is the subject of the invention, the term "crosslinked anionic polyelectrolyte (AP1)" means a non-linear crosslinked anionic polyelectrolyte in the form of a three-dimensional network that is insoluble in water but swells in water and leads to the production of a chemical gel.
[0107] Preferably, the crosslinked anionic polyelectrolyte (AP1) comprises, per 100 mol %:
[0108] (a1) a proportion of greater than or equal to 25 mol % and less than or equal to 100 mol % of monomer units derived from 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid in the form of the free acid or in partially or completely salified form;
[0109] (a2) - Optionally, a proportion greater than 0 mol % and less than or equal to 75 mol % of monomer units derived from at least one monomer selected from the group consisting of: acrylamide, N,N-dimethylacrylamide; methacrylamide or N-isopropylacrylamide;
[0110] (a3) - Optionally, a proportion greater than 0 mol% and less than or equal to 20 mol%, more particularly greater than 0 mol% and less than or equal to 15 mol%, still more particularly greater than or equal to 0 mol% and less than or equal to 10 mol% of monomer units derived from at least one monomer selected from the group consisting of elements of (2-hydroxyethyl) acrylate, (2,3-dihydroxypropyl) acrylate, (2-hydroxyethyl) methacrylate, (2,3-dihydroxypropyl) methacrylate and vinylpyrrolidone;
[0111] (a4) - Optionally, a proportion greater than 0 mol % and less than or equal to 75 % of monomer units derived from at least one monomer selected from the group consisting of acrylic acid, methacrylic acid, 2-carboxyethylacrylic acid, itaconic acid, maleic acid and 3-methyl-3-[(1-oxo-2-propenyl)amino]butyric acid, the carboxylic acid function of said monomer being in the free acid, partially or completely salified form;
[0112] (a5) - Optionally, a proportion greater than 0 mol % and less than or equal to 5 mol % of at least one monomer of formula (M1):
[0113] [Chemical formula 3]
[0114]
[0115] wherein R represents a straight or branched alkyl group containing from eight to twenty carbon atoms, and n represents an integer greater than or equal to zero and less than or equal to twenty;
[0116] (a6) - a proportion greater than 0 mol % and less than or equal to 1 mol % of monomer units derived from at least one diene or polyene crosslinking monomer (AR); the sum of the molar proportions of said monomer units according to a1), a2), a3), a4), a5) and a6) is equal to 100 mol %.
[0117] For the purposes of the present invention, the term "salified" means that the acid functions present in the monomers are in the form of anions associated in salt form with cations, in particular alkali metal salts, such as sodium or potassium cations, or cations of nitrogenous bases, such as ammonium salts, lysine salts or monoethanolamine salts (HOCH2-CH2-NH4 + ). They are preferably sodium salts or ammonium salts.
[0118] In the definition of the crosslinked anionic polyelectrolyte (AP1), at least one diene or polyene crosslinking monomer (AR) particularly indicates a monomer of an element selected from the group consisting of: methylene bis(acrylamide), ethylene glycol dimethacrylate, diethylene glycol diacrylate, ethylene glycol diacrylate, diallyl urea, triallylamine, trimethylolpropane triacrylate, diallyloxyacetic acid or one of its salts (such as sodium diallyloxyacetate), or a mixture of these compounds; and more particularly a monomer selected from the group consisting of: ethylene glycol dimethacrylate, triallylamine, trimethylolpropane triacrylate or methylene bis(acrylamide) or a mixture of these compounds.
[0119] According to another particular aspect of the invention, the composition for topical use (E1) is characterized in that the crosslinking monomer (AR) as defined above is used in a molar proportion less than or equal to 0.5%, more particularly less than or equal to 0.25% and most particularly less than or equal to 0.1%; it is more particularly greater than or equal to 0.005 mol%.
[0120] The crosslinked anionic polyelectrolyte (AP1) used in the composition for topical use (E1) that is the subject of the invention may also comprise various additives, such as complexing agents, transfer agents or chain limiters.
[0121] The crosslinked anionic polyelectrolyte (AP1) used in the composition for topical use (E1) that is the subject of the invention can be prepared by carrying out free radical polymerization processes known to those skilled in the art, for example solution polymerization, suspension polymerization, inverse suspension polymerization, emulsion polymerization, inverse emulsion polymerization or polymerization in a solvent medium, followed by a precipitation step of the polymer formed.
[0122] According to a more specific aspect, the crosslinked anionic polyelectrolyte (AP1) used in the composition for topical use (E1) that is the subject of the invention can be prepared by a process carrying out a polymerization in a solvent medium, followed by a precipitation step of the polymer formed, or an inverse emulsion polymerization, optionally followed by a concentration and / or atomization step.
[0123] According to a more specific aspect, the crosslinked anionic polyelectrolyte (AP1) used in the composition for topical use (E1) that is the subject of the invention can be prepared according to one of the processes described above and can involve the use of transfer agents or chain limiters. The transfer agents or chain limiters are more particularly selected from the group consisting of sodium hypophosphite, low molecular weight alcohols such as methanol, ethanol, 1-propanol, isopropanol or butanol, thiols such as 2-mercaptoethanol, transfer agents containing sulfate functions such as sodium methallyl sulfonate, or mixtures of said transfer agents. The transfer agents or chain limiters are more particularly used in a molar proportion of 0.001 mol% to 1 mol%, more particularly 0.001 mol% to 0.5 mol% and very particularly 0.001 mol% to 0.1 mol%, expressed in relation to the total number of moles of the monomers used.
[0124] According to another specific aspect of the present invention, the crosslinked anionic polyelectrolyte (AP1) is an element of the group consisting of: a homopolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt, crosslinked with triallylamine and / or methylenebis(acrylamide); a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt and acrylic acid partially or completely salified in the form of a sodium salt or an ammonium salt, crosslinked with triallylamine and / or methylenebis(acrylamide); a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt, crosslinked with triallylamine and / or methylenebis(acrylamide); A copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) and acrylic acid (δ) partially or completely salified in the form of a sodium salt, crosslinked with triallylamine and / or methylenebis(acrylamide) in a molar ratio (γ) / (δ) of greater than or equal to 30 / 70 and less than or equal to 90 / 10; a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) partially or completely salified in the form of a sodium salt, and acrylic acid (δ) partially or completely salified in the form of a sodium salt, crosslinked with triallylamine and / or methylenebis(acrylamide) in a molar ratio (γ) / (δ) of greater than or equal to 40 / 60 and less than or equal to 90 / 10; a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) partially or completely salified in the form of a sodium salt, and acrylic acid (δ) partially or completely salified in the form of a sodium salt, crosslinked with triallylamine and / or methylenebis(acrylamide) in a molar ratio (γ) / (δ) of greater than or equal to 40 / 60 and less than or equal to 90 / 10; A copolymer of methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) and acrylamide (ε) in a molar ratio (γ) / (ε) greater than or equal to 30 / 70 and less than or equal to 90 / 10, crosslinked with triallylamine and / or methylenebis(acrylamide); a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) and hydroxyethyl acrylate (ζ) in a molar ratio (γ) / (ζ) greater than or equal to 30 / 70 and less than or equal to 90 / 10, crosslinked with triallylamine and / or methylenebis(acrylamide); a copolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (γ) partially or completely salified in the form of a sodium salt and hydroxyethyl acrylate (ζ) in a molar ratio (γ) / (ζ) greater than or equal to 30 / 70 and less than or equal to 90 / 10, crosslinked with triallylamine and / or methylenebis(acrylamide); a copolymer of 2-methyl-2-[( A terpolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid, acrylamide and acrylic acid partially or completely salified in the form of a sodium salt or an ammonium salt, crosslinked with triallylamine and / or methylenebis(acrylamide); a terpolymer of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt, acrylamide greater than or equal to 45% and less than 68% and acrylic acid partially or completely salified in the form of a sodium salt or an ammonium salt, crosslinked with triallylamine and / or methylenebis(acrylamide);A terpolymer crosslinked with triallylamine and / or methylenebis(acrylamide) containing 30% or more and 45% or less of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt, 47% or more and 68% or less of acrylamide and 2% or more and 8% or less of acrylic acid partially or completely salified in the form of a sodium salt or an ammonium salt; a terpolymer crosslinked with triallylamine and / or methylenebis(acrylamide) containing 60% or more and 80% or less of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium salt or an ammonium salt, 15% or more and 39.5% or less of N,N-dimethylacrylamide and 0.5% or more and less of terpolymers of tetraethoxylated lauryl methacrylate in an amount of 5% or more and crosslinked with trimethylolpropane triacrylate and / or triallylamine and / or methylenebis(acrylamide); terpolymers of 60% or more and 80% or less of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid partially or completely salified in the form of a sodium or ammonium salt, 15% or more and 39% or less of N,N-dimethylacrylamide, 0.5% or more and 2.5% or less of lauroyl methacrylate, and 0.5% or more and 2.5% or less of stearyl methacrylate crosslinked with trimethylolpropane triacrylate and / or triallylamine and / or methylenebis(acrylamide). ;
[0125] With regard to the emulsifying surfactant, in formula (VII) as defined above, the group R1-O- is linked to G via the anomeric carbon of the sugar residue so as to form an acetal function.
[0126] According to a specific aspect, in the definition of formula (VII), x or the average degree of polymerization represents a decimal greater than or equal to 1.05 and less than or equal to 2.5, more particularly greater than or equal to 1.05 and less than or equal to 2.0 and still more particularly greater than or equal to 1.25 and less than or equal to 2.0.
[0127] According to another specific aspect, the combination of at least one emulsifying surfactant (S1) and at least one emulsifying surfactant (S2) comprises, per 100% by weight thereof:
[0128] - from 12 to 88% by weight of at least one emulsifying surfactant (S1), consisting of at least one composition (C2) comprising, per 100% by weight thereof:
[0129] * From 10% to 50% by weight of at least one alkyl polyglycoside composition (C1) represented by formula (VII):
[0130] R1-O-(G) x -H (VII)
[0131] wherein x represents a decimal between 1.05 and 2.5, G represents a glucosyl group or an α,β-D-glucopyranose group obtained by removing a hemiacetal hydroxyl group from α,β-D-glucopyranose, and R1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, the composition consisting of a mixture of compounds represented by formulae (VII1), (VII2), (VII3), (VII4) and (VII5):
[0132] R1-O-(G)1-H (VII1)
[0133] R1-O-(G)2-H (VII2)
[0134] R1-O-(G)3-H (VII3)
[0135] R1-O-(G)4-H (VII4)
[0136] R1-O-(G)5-H (VII5)
[0137] These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5 such that:
[0138] -The sum of a1+a2+a3+a4+a5 is equal to 1, and
[0139] -the sum of a1+2a2+3a3+4a4+5a5 equals x; and
[0140] * From 90 to 50% by weight of at least one fatty alcohol of formula (IX):
[0141] R"1-OH (IX),
[0142] wherein R"1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, wherein R"1 may be the same as or different from R1;
[0143] - from 12 to 88% by weight of at least one emulsifying surfactant (S2) consisting of at least one polyglycol polyhydroxystearate represented by formula (XII):
[0144] [Chemical formula 4]
[0145]
[0146] wherein y2 represents an integer greater than or equal to 2 and less than or equal to 50, R4 represents a hydrogen atom, a methyl group or an ethyl group, and Z2 represents a group having the formula (XIII):
[0147] [Chemical formula 5]
[0148]
[0149] wherein y'2 represents an integer greater than or equal to 0 and less than or equal to 10, more particularly greater than or equal to 1 and less than or equal to 10, and Z'2 represents: a group of formula (XIII) as defined above, wherein Z2' may be the same as or different from Z2; or a hydrogen atom.
[0150] With regard to the emulsifying surfactant, in formula (VIII) as defined above, the group R1-O- is linked to G via the anomeric carbon of the sugar residue so as to form an acetal functional group.
[0151] According to a specific aspect, in the definition of formula (VIII), x or the average degree of polymerization represents a decimal greater than or equal to 1.05 and less than or equal to 2.5, more particularly greater than or equal to 1.05 and less than or equal to 2.0 and still more particularly greater than or equal to 1.25 and less than or equal to 2.0.
[0152] According to another specific aspect, the combination of at least one emulsifying surfactant (S1) and at least one emulsifying surfactant (S2) comprises, per 100% by weight thereof:
[0153] - from 12 to 88% by weight of at least one emulsifying surfactant (S1), consisting of at least one composition (C'2) comprising, per 100% by weight thereof:
[0154] From 10% to 50% by weight of at least one alkyl polyglycoside composition (C'1) represented by formula (X):
[0155] R1-O-(G) x -H (X)
[0156] wherein x represents a decimal between 1.05 and 2.5, G represents a xylose residue, and R1 represents 2-octyldodecyl, the composition consisting of a mixture of compounds represented by formula (X1), (X2), (X3), (X4) and (X5):
[0157] R1-O-(G)1-H (X1)
[0158] R1-O-(G)2-H (X2)
[0159] R1-O-(G)3-H (X3)
[0160] R1-O-(G)4-H (X4)
[0161] R1-O-(G)5-H (X5)
[0162] These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5 such that:
[0163] The sum of a1+a2+a3+a4+a5 is equal to 1, and
[0164] The sum of a1+2a2+3a3+4a4+5a5 equals x; and
[0165] From 90 to 50% by weight of at least one fatty alcohol of formula (XI):
[0166] R''1-OH (XI),
[0167] Wherein R"'1 represents 2-octyldodecyl;
[0168] - from 12 to 88% by weight of at least one emulsifying surfactant (S2) consisting of at least one polyglycol polyhydroxystearate represented by formula (XII):
[0169] [Chemical formula 6]
[0170]
[0171] wherein y2 represents an integer greater than or equal to 2 and less than or equal to 50, R4 represents a hydrogen atom, a methyl group or an ethyl group, and Z2 represents a group having the formula (XIII):
[0172] [Chemical formula 7]
[0173]
[0174] wherein y'2 represents an integer greater than or equal to 0 and less than or equal to 10, more particularly greater than or equal to 1 and less than or equal to 10, and Z'2 represents: a group of formula (XIII) as defined above, wherein Z2' may be the same as or different from Z2; or a hydrogen atom.
[0175] According to another specific aspect, the composition for topical use (E1) according to the invention has a dynamic viscosity greater than or equal to 500 mPa.s and less than or equal to 40000 mPa.s, measured at a temperature of 20°C using a Brookfield LVT viscometer at a speed of 6 rpm.
[0176] As auxiliary compounds, among the foaming and / or detergent anionic surfactants that can be combined with the composition (E1) for topical use according to the invention, mention may be made of alkyl ether sulfates, alkyl sulfates, alkylamido ether sulfates, alkylaryl polyether sulfates, monoglyceride sulfates, α-olefin sulfonates, paraffin sulfonates, alkyl phosphates, alkyl ether phosphates, alkyl sulfonates, alkylamido sulfonates, alkylaryl sulfonates, alkyl carboxylates, alkyl sulfosuccinates, alkyl ether sulfosuccinates, alkylamido sulfosuccinates, alkyl sulfoacetates, alkyl sarcosinates, acyl isethionates, N-acyl taurates, acyl lactylates, N-acylated derivatives of amino acids, N-acylated derivatives of peptides, N-acylated derivatives of proteins, or alkali metal salts, alkaline earth metal salts, ammonium salts, amine salts, or amino alcohol salts of fatty acids.
[0177] Among the foaming and / or detergent amphoteric surfactants optionally present in the compositions (E1) for topical use according to the invention, mention may be made of alkyl betaines, alkylamidobetaines, sultaines, alkylamidoalkylsultaines, imidazoline derivatives, phosphobetaines, amphoteric polyacetates and amphoteric propionates.
[0178] Among the foaming and / or detergent cationic surfactants optionally present in the compositions (E1 ) for topical use according to the invention, mention may in particular be made of quaternary ammonium derivatives.
[0179] Among the foaming and / or detergent nonionic surfactants optionally present in the composition (E1) for topical use according to the invention, mention may be made more particularly of alkyl polyglycosides containing linear or branched, saturated or unsaturated aliphatic radicals and comprising from 8 to 12 carbon atoms; castor oil derivatives, polysorbates, cocoamide and N-alkylamines.
[0180] As examples of thickening and / or gelling surfactants optionally present in the composition for topical use (E1) according to the invention, mention may be made of:
[0181] - optionally alkoxylated alkyl polyglucosides fatty esters, and most particularly ethoxylated methyl polyglucosides, such as those sold under the name Glucamate TM LT and Glumate TM PEG 120 methyl glucose trioleate and PEG 120 methyl glucose dioleate sold by DOE120;
[0182] - Alkoxylated fatty esters, such as those sold under the name Crothix TM DS53 is sold as PEG 150 pentaerythritol tetrastearate, or under the name AntilTM PEG 55 propylene glycol oleate sold at 141;
[0183] - fatty chain polyalkylene glycol urethanes, such as those sold under the name Elfacos TM PPG 14 Laureth Isophoryl Diurethane sold as T211, or under the name Elfacos TM GT2125 sells PPG 14 Palm Oleth 60 Hexyl Diurethane.
[0184] As examples of emulsifying surfactants optionally present in the composition for topical use (E1) according to the invention, mention may be made of nonionic surfactants, anionic surfactants and cationic surfactants.
[0185] As examples of emulsifying nonionic surfactants optionally present in the composition (E1) for topical use according to the invention, ethoxylated castor oil and ethoxylated hydrogenated castor oil, for example available under the name Simulsol TM 989; compositions comprising glyceryl stearate and poly(ethoxylated) stearic acid with between 5 mol and 150 mol of ethylene oxide, for example compositions comprising (ethoxylated) stearic acid with 135 mol of ethylene oxide and glyceryl stearate (marketed under the name Simulsol TM 165); ethoxylated sorbitan esters, for example under the name Montanox TM Products sold; Ethoxylated anhydromannitol esters; Sucrose esters; Methyl glucoside esters.
[0186] As examples of emulsifying anionic surfactants that may be present in the composition (E1) for topical use according to the invention, mention may be made of decyl phosphate, TM Sold Cetyl Phosphate, Stearic Acid Citrate Glyceryl; Cetearyl Sulfate; under the name Sensanov TM a soap, such as sodium stearate or triethanolammonium stearate, or an N-acylated derivative of a salified amino acid, such as stearoyl glutamate.
[0187] As examples of emulsifying cationic surfactants optionally present in the composition (E1) for topical use according to the invention, mention may be made of amine oxides, Quaternium-82, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, and the surfactants described in document WO 96 / 00719, and mainly those in which the fatty chain contains at least 16 carbon atoms.
[0188] Mention may be made, as examples of opacifying and / or pearlizing agents optionally present in the composition (E1) for topical use according to the invention, of sodium palmitate, sodium stearate, sodium hydroxystearate, magnesium palmitate, magnesium stearate, magnesium hydroxystearate, ethylene glycol monostearate, ethylene glycol distearate, polyethylene glycol monostearate, polyethylene glycol distearate, and fatty alcohols containing from 12 to 22 carbon atoms.
[0189] As examples of texturizing agents optionally present in the composition for topical use (E1) according to the invention, mention may be made of N-acylated derivatives of amino acids, for example those known under the name Aminohope TM Lauroyl lysine sold by LL under the name Dryflo TM Octenyl starch succinate sold under the name Montanov 14, myristyl polyglucoside sold under the name Montanov 14, cellulose fibers, cotton fibers, chitosan fibers, talc, sericite and mica.
[0190] As examples of solvents and cosolvents optionally present in the composition for topical use (E1) according to the invention, mention may be made of water, organic solvents such as glycerol, diglycerol, glycerol oligomers, ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, diethylene glycol, xylitol, erythritol, sorbitol, water-soluble alcohols such as ethanol, isopropanol or butanol, mixtures of water and the organic solvents mentioned, propylene carbonate, ethyl acetate, benzyl alcohol and dimethyl sulfoxide (DMSO).
[0191] As examples of agents for improving skin permeability which may be optionally present in the composition (E1) for topical use according to the invention, mention may be made of glycol ethers (e.g. ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monophenyl ether, ethylene glycol monobenzyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether and diethylene glycol monon-butyl ether, diethylene glycol monoethyl ether (or Transcutol-P)), fatty acids (e.g. oleic acid), fatty acid esters of glycerol (e.g. behenyl glyceryl, palmitostearyl glyceryl, behenyl macroglyceride), polyoxyethylene-2-stearyl ether, polyoxyethylene-2-oleyl ether, terpenes (e.g. D-limonene), and essential oils (e.g. essential oil of eucalyptus).
[0192] As examples of thickeners and / or gelling agents optionally present in the composition for topical use (E1) according to the invention, mention may be made of polysaccharides consisting exclusively of monosaccharides, such as dextran or glucose homopolymers, glucomannan glucan, xyloglucan, galactomannans in which the degree of substitution (DS) of the D-galactose units on the main D-mannose chain is between 0 and 1, and more particularly between 1 and 0.25, such as galactomannans derived from cassia gum (DS=1 / 5), locust bean gum (DS=1 / 4), tara gum (DS=1 / 3), guar gum (DS=1 / 2) or fenugreek gum (DS=1).
[0193] As examples of thickening and / or gelling agents optionally present in the composition for topical use (E1) according to the invention, mention may be made of polysaccharides composed of monosaccharide derivatives, such as sulfated galactans and more particularly carrageenan and agar, uronans and more particularly algin, alginates and pectin, heteropolymers of monosaccharides and uronic acid and more particularly xanthan gum, gellan gum, gum arabic exudate and gum karaya exudate, and glycosaminoglycans.
[0194] As examples of thickeners and / or gelling agents optionally present in the composition for topical use (E1) according to the invention, mention may be made of cellulose, cellulose derivatives such as methylcellulose, ethylcellulose, hydroxypropylcellulose, silicates, starch, hydrophilic starch derivatives and polyurethanes.
[0195] As examples of stabilizers optionally present in the composition (E1) for topical use according to the invention, mention may be made of microcrystalline waxes, and more particularly ozokerite, and inorganic salts such as sodium chloride or magnesium chloride.
[0196] As examples of thermal or mineral waters with which the composition for topical use (E1) according to the invention can be combined, mention may be made of thermal or mineral waters having a mineralization content of at least 300 mg / l, in particular Avene water, Vittel water, Vichy basin water, Uriage water, La Roche-Posay water, La Bourboule water, Enghien-les-Bains water, Saint-Gervais-les-Bains water, Néris-les-Bains water, Allevard-les-Bains water, Digne water, Maizières water, Neyrac-les-Bains water, Lons-le-Saunier water, Rochefort water, Saint-Gervais-les-Bains water, Néris-les-Bains water, Allevard-les-Bains water, Digne water, Maizières water, Neyrac-les-Bains water, Lons-le-Saunier water, Rochefort water, Saint-Gervais-les-Bains water, Christau water, Les Fumades water and Tercis-les-Bains water.
[0197] As examples of active agents with which the composition for topical use (E1) according to the invention can be combined, mention may be made of substances or compositions that provide a beneficial effect to a human or animal subject.
[0198] As examples of deodorants that may be present in the composition (E1) for topical use that is the subject of the invention, mention may be made of alkali metal silicates, zinc salts such as zinc sulfate, zinc gluconate, zinc chloride or zinc lactate; quaternary ammonium salts such as cetyltrimethylammonium salt or cetylpyridinium salt; glycerol derivatives such as glyceryl caprate, glyceryl caprylate or polyglyceryl caprate; 1,2-decanediol, 1,3-propylene glycol; salicylic acid; sodium bicarbonate; cyclodextrins; metal zeolites; Triclosan TM ; hydrated aluminum bromide, hydrated aluminum chlorohydrate, aluminum chloride, aluminum sulfate, hydrated aluminum zirconium chlorohydrate, hydrated aluminum zirconium trichloride, hydrated aluminum zirconium tetrachloride, hydrated aluminum zirconium pentachloride, hydrated aluminum zirconium octachloride, aluminum sulfate, sodium aluminum lactate, or a complex of aluminum chlorohydrate and a glycol, such as a complex of aluminum chlorohydrate and propylene glycol, a complex of aluminum dichloride hydrate and propylene glycol, a complex of hydroxyaluminum sesquichlorohydrate and propylene glycol, a complex of aluminum chlorohydrate and polyethylene glycol, a complex of aluminum dichloride hydrate and polyethylene glycol, or a complex of hydroxyaluminum sesquichlorohydrate and polyethylene glycol.
[0199] As examples of antioxidants that may be present in the composition for topical use (E1) that is the subject of the invention, mention may be made of EDTA and its salts, citric acid, tartaric acid, oxalic acid, BHA (butylated hydroxyanisole), BHT (butylated hydroxytoluene), tocopherol derivatives such as tocopheryl acetate, mixtures of antioxidant compounds such as Dissolvine GL 47S (INCI name: Tetrasodium Glutamate Diacetate).
[0200] Among the active ingredients that may be included in the composition for topical use (E1) that is the subject of the present invention, mention may be made of:
[0201] Vitamins and their derivatives, in particular their esters, such as retinol (vitamin A) and its esters (e.g. retinyl palmitate), ascorbic acid (vitamin C) and its esters, sugar derivatives of ascorbic acid (e.g. ascorbyl glucoside), tocopherol (vitamin E) and its esters (e.g. tocopheryl acetate), vitamin B3 or B10 (niacinamide and its derivatives); compounds showing a soothing effect, in particular Sepicalm TM S, allantoin and bisabolol; anti-inflammatory agents; compounds that exhibit moisturizing effects, such as urea, hydroxyurea, glyceryl glucoside, diglyceryl glucoside, polyglyceryl glucoside, glyceryl polyglucoside, diglyceryl polyglucoside, and xylityl polyglucoside (trade name Aquaxyl TM Plant extracts rich in polyphenols, such as grape extract, pine extract, wine extract or olive extract; compounds showing anti-obesity or lipolytic effects, such as caffeine or its derivatives, Adiposlim TM 、Adipoless TM , or fucoxanthin; N-acylated proteins; N-acylated peptides such as Matrixil TM ; N-acylated amino acids; partial hydrolysates of N-acylated proteins; amino acids; peptides; total hydrolysates of proteins; soy extracts, such as Raffermine TM ; Wheat extracts, such as Tensine TM or Gliadine TM ; plant extracts, such as tannin-rich plant extracts, isoflavone-rich plant extracts or terpene-rich plant extracts; extracts of freshwater algae or seaweed; marine plant extracts; marine extracts, typically coral; essential wax; bacterial extracts; ceramides; phospholipids; compounds showing antimicrobial or purifying effects, such as Lipacide TM C8G、Lipacide TM UG, Sepicontrol TM A5, OctopiroxTM or Sensiva TM SC50; Compounds that display stimulatory or stimulating properties, such as Physiogenyl TM , or panthenol and its derivatives such as Sepicap TM MP; Anti-aging active ingredients such as Sepilift TM DPHP、Lipacide TM PVB, Sepivinol TM , Sepivita TM , Manoliva TM 、Phyto-Age TM 、Timecode TM or Survicode TM; anti-photoaging active ingredients; active ingredients that protect the integrity of the dermal-epidermal junction; active ingredients that increase the synthesis of extracellular matrix components, such as collagen, elastin or glycosaminoglycans; active ingredients that act favorably on chemical cell communication, such as cytokines, or on physical cell communication, such as integrins; active ingredients that produce a "warming" sensation on the skin, such as skin microcirculation activators (such as niacin derivatives) or products that produce a "cooling" sensation on the skin (such as menthol and derivatives); active ingredients that improve skin microcirculation, such as venotonics; drainage active ingredients; active ingredients with a decongestive purpose, such as ginkgo, ivy, horse chestnut, bamboo, ruscus, butcher's broom, Centalla asiatica, etc. asiatica), rockweed, rosemary or willow; agents for tanning or darkening the skin, such as, for example, dihydroxyacetone (DHA), erythrulose, mesotartaric aldehyde, glutaraldehyde, glyceraldehyde, alloxan, ninhydrin, plant extracts, such as, for example, extracts of rosewoods of the genera Pterocarpus and Baphia, for example Pterocarpus santalinus, Pterocarpus osun, Pterocarpus soyauxii, Pterocarpuserinaceus, Pterocarpus indicus or Baphia nitida, as described in European Patent Application EP 0 971 683; agents known for their effect of promoting and / or accelerating the tanning or darkening of human skin and / or for their effect of pigmenting human skin, such as, for example, carotenoids (and more particularly β-carotene and γ-carotene), the products sold under the trade name Carrot oil (INCI name: Daucus carota, Helianthus annuus sunflower oil) by the company Provital, which contain carotenoids, vitamin E and vitamin K; tyrosine and / or its derivatives, known for their effect of accelerating the tanning of human skin in combination with exposure to ultraviolet radiation, for example, sold under the trade name SunTan Accelerator by the company Provital TM A product sold under the trade name MelanoBronze by Mibelle that contains tyrosine and riboflavin (vitamin B), a tyrosine and tyrosinase complex sold under the trade name Zymo Tan Complex by Zymo Line, and a tyrosinase complex sold under the trade name MelanoBronze by Mibelle. TM(INCI name: Acetyl Tyrosine, Monk's Pepper Extract (Vitex agnus-castus)), which contains acetyl tyrosine, the product sold by the company Unipex under the trade name Unipertan VEG-24 / 242 / 2002 (INCI name: Butylene Glycol and Acetyl Tyrosine with Hydrolyzed Vegetable Protein and Adenosine Triphosphate), the product sold by the company Sederma under the trade name Try-Excell TM A product sold under the trade name Actibronze TM (INCI name: Hydrolyzed Wheat Protein with Acetyl Tyrosine and Copper Gluconate) sold by Synerga under the brand name Tyrostan TM (INCI name: Potassium Caproyl Tyrosinate), the product sold by Synerga under the brand name Tyrosinol (INCI name: Sorbitan Isostearate, Glyceryl Oleate, Caproyl Tyrosine), the product sold by Alban Muller under the brand name InstaBronze TM products sold under the brand name Tyrosilane (INCI name: Methylsilanol and Acetyl Tyrosine) by the company Exymol; peptides known for their melanogenesis-activating effect, such as the product sold under the brand name Bronzing SF Peptide Powder (INCI name: Glucan and Octapeptide-5) by the company Infinitec Activos, the product sold under the brand name Melitane (INCI name: Glycerin and Water and Glucan and Acetyl Hexapeptide-1), which contains Acetyl Hexapeptide-1 known for its α-MSH agonist effect, and the product sold under the brand name Melatimes Solutions by the company Lipotec TM Products sold under the trade name Tanositol TM (INCI name: Inositol), sold by Codif International under the trade name Thalitan TM (or Phycosaccharide TMMelactiva AG (INCI name: Water and hydrolyzed alginate (Laminaria digitata) and magnesium and manganese sulfates), which contains oligosaccharides of marine origin (guluronic acid and mannuronic acid chelated with magnesium and manganese ions), is marketed by Alban Muller under the trade name Melactiva TM (INCI name: Maltodextrin, Mucuna pruriens seed extract), rich in flavonoid compounds, such as the product sold by Silab under the brand name Biotanning (INCI name: Hydrolyzed citrus Aurantium dulcis fruit extract) and known to be rich in citric flavonoids (hesperidins).
[0202] As examples of sunscreens optionally present in the composition for topical use (E1 ) that is subject of the invention, mention may be made of all those listed in the Cosmetic Directive 76 / 768 / EEC, Annex VII, as amended.
[0203] Among the organic sunscreens optionally present in the composition for topical use (E1) that is a subject of the invention, mention may be made of:
[0204] - benzoic acid derivatives, such as para-aminobenzoic acid (PABA), in particular the monoglyceride of PABA, the ethyl ester of N,N-propoxy PABA, the ethyl ester of N,N-diethoxy PABA, the ethyl ester of N,N-dimethyl PABA, the methyl ester of N,N-dimethyl PABA, the butyl ester of N,N-dimethyl PABA;
[0205] - anthranilic acid derivatives, such as trimethylcyclohexyl N-acetyl anthranilate;
[0206] - salicylic acid derivatives, such as amyl salicylate, trimethylol salicylate, ethylhexyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropylphenyl salicylate;
[0207] - cinnamic acid derivatives, such as ethylhexyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, p-methoxypropyl cinnamate, p-methoxyisopropyl cinnamate, p-methoxyisoamyl cinnamate, p-methoxyoctyl cinnamate (p-methoxy-2-ethylhexyl cinnamate), p-methoxy-2-ethoxyethyl cinnamate, p-methoxycyclohexyl cinnamate, ethyl-α-cyano-β-phenyl cinnamate, 2-ethylhexyl-α-cyano-β-phenyl cinnamate, glyceryl di-p-methoxy-mono-2-ethylhexanoyl cinnamate;
[0208] -benzophenone derivatives, such as 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone 5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenylbenzophenone 2-formate, 2-hydroxy-4-n-octyloxybenzophenone, 4-hydroxy-3-carboxybenzophenone; 3-(4'-methylbenzylidene)-d,l-camphor, 3-(benzylidene)-d,l-camphor, camphor benzalkonium methyl sulfate; urocanic acid, ethyl urocanate; sulfonic acid derivative family such as 2-phenylbenzimidazole-5-sulfonic acid and its salts;
[0209] - triazine derivatives, such as hydroxyphenyl triazine, (ethylhexyloxyhydroxyphenyl) (4-methoxyphenyl) triazine, 2,4,6-trianilino (p-carbonyl (carbo)-2'-ethylhexyl-1'-oxy)-1,3,5-triazine, 4,4-((6-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-triazine-2,4-diyldiimino)bis-(2-ethylhexyl) benzoate, 2-phenyl-5-methylbenzoxazole, 2,2'-hydroxy-5-methylphenylbenzotriazole, 2-(2'-hydroxy-5'-tert-octylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole; dibenzazine; di-p-methoxybenzoylmethane, 4-methoxy-4"-tert-butylbenzoylmethane; 5-(3,3-dimethyl-2-norbornene)-3-pentan-2-one;
[0210] - diphenylacrylate derivatives, such as 2-ethylhexyl 2-cyano-3,3-diphenyl-2-acrylate or 2-cyano-3,3-diphenyl-2-acrylate ethyl ester;
[0211] - Polysiloxanes, such as benzalsiloxane malonate.
[0212] Among the inorganic sunscreens (also called "mineral sunscreens") that may be present in the composition for topical use (E1) that is the subject of the invention, mention may be made of titanium oxide, zinc oxide, cerium oxide, zirconium oxide, yellow, red or black iron oxides, and chromium oxide. These inorganic sunscreens may or may not be micronized, may or may not have undergone a surface treatment and may optionally be present in the form of an aqueous or oily predispersion.
[0213] The composition according to the invention and as defined above is obtained by carrying out a preparation process comprising the following steps:
[0214] The fat phase (A2) is prepared by mixing all the elements constituting the fat phase (A2) in the desired proportions. Step a). The mixing step is generally carried out at a temperature greater than or equal to 20° C. and less than or equal to 80° C., more particularly greater than or equal to 25° C. and less than or equal to 80° C., and even more particularly greater than or equal to 30° C. and less than 80° C.; it is carried out under mechanical stirring at a moderate speed greater than or equal to 50 rpm and less than or equal to 100 rpm;
[0215] The aqueous phase (A1) is prepared from all the elements constituting it in the desired proportions. Step b) The mixing step is generally carried out at a temperature greater than or equal to 20°C and less than or equal to 80°C, more particularly greater than or equal to 20°C and less than or equal to 60°C, and still more particularly greater than or equal to 20°C and less than 40°C; it is carried out under mechanical stirring at a moderate speed greater than or equal to 500 rpm and less than or equal to 3000 rpm. Specifically, at Step b) the aqueous phase (A1) obtained at the end has a dynamic viscosity, measured at 20° C. using a Brookfield LV viscometer at a speed of 6 rpm, greater than or equal to 200 mPa.s and less than or equal to 40 000 mPa.s, more particularly greater than or equal to 1000 mPa.s and less than or equal to 40 000 mPa.s and even more particularly greater than or equal to 2000 mPa.s and less than or equal to 40 000 mPa.s;
[0216] Step c) , wherein the fatty phase (A2) is added to the aqueous phase (A1) at a temperature greater than or equal to 20° C. and less than or equal to 80° C., more particularly greater than or equal to 20° C. and less than or equal to 60° C. and still more particularly greater than or equal to 20° C. and less than or equal to 40° C., under mechanical stirring at a moderate speed greater than or equal to 50 rpm and less than or equal to 400 rpm, so as to obtain the composition according to the invention.
[0217] The following examples illustrate the invention without however limiting it.
[0218] Preparation and evaluation of emulsions according to the invention and comparative emulsions
[0219] 1) Preparation of emulsions according to the present invention and comparative emulsions
[0220] Three emulsions according to the present invention (denoted as (F1) to (F3)) and four comparative emulsions (denoted as (F'1) to (F'4)) were prepared by the following method, the weight proportions of their components are recorded in the following Table 1, and the weight content of polyelectrolyte is expressed as a percentage of polymer solids.
[0221] The components of the fat phase are introduced successively into a beaker, mixed and, after a heating step at 80° C., brought to a temperature of 20° C.; mixing is carried out using a mechanical stirrer equipped with a propeller stirring shaft at a speed of 100 rpm.
[0222] The ingredients of the dispersed phase are mixed in a beaker at ambient temperature using a mechanical stirrer at a speed of 2000 rpm, and then the thickener is gradually added. Stirring is maintained for a period of time, which makes it possible to obtain a phase in the form of a homogeneous gel. At ambient temperature and a medium stirring speed (75 to 300 rpm), the fat phase is added once to the gel using a stirrer equipped with an anchor shaft. The stirring is then continued for 10 minutes, and no cooling step is required.
[0223] [Table 1]
[0224]
[0225] (1) Lanol TM 2681, or coco-caprylate / caprate.
[0226] (2) Sepineo TM SE 68 is a mixture used as an emulsifier, comprising, per 100% of its weight, from 78 to 85% by weight of a mixture of n-hexadecyl alcohol and n-octadecyl alcohol, and from 15 to 22% by weight of a mixture of n-hexadecyl glucoside having an average degree of polymerization of 1.20 and n-octadecyl glucoside having an average degree of polymerization of 1.20.
[0227] (3) Sepicide TM HB is a mixture of phenoxyethanol, methylparaben, ethylparaben, butylparaben and n-propylparaben used as preservatives.
[0228] (4) Simaline TM WO, or PEG 30 dipolyhydroxystearate is an emulsifying surfactant.
[0229] (5) : Sepineo TM P600 is a self-reversible inverse latex used as a thickener, containing, per 100% of its weight, between 30% and 40% by weight of a crosslinked copolymer of acrylamide and sodium acryloyldimethyltaurate.
[0230] (6) Montane TM 80 is a composition comprising sorbitan monooleate used as a water-in-oil emulsifier.
[0231] (7): PEG-400 has a molecular weight of approximately 400 g.mol -1 Molecular weight of polyethylene glycol.
[0232] (8) Montanov TM 202 is a mixture for use as an emulsifier, comprising from 80 to 90% by weight of a mixture of arachidyl alcohol and behenyl alcohol, and from 10 to 20% by weight of arachidyl polyglucoside having an average degree of polymerization of 1.20, per 100% by weight thereof.
[0233] (9) Fluidanov TM 20X is a mixture comprising from 70 to 90% by weight of 2-octyl-1-dodecanol and from 10 to 30% by weight of 2-octyl-1-dodecyl polyxyloside per 100% by weight thereof.
[0234] (*) Minimum weight proportion of water that can be added to the corresponding comparative emulsions (F'2), (F'3), (F'4) without obtaining a gelling that prevents the stirring of said emulsion or obtaining an emulsion exhibiting an inhomogeneous appearance (which persists despite the stirring phase of the preparation process) or in the form of a dispersed phase in the form of a fatty phase.
[0235] 2 Demonstration of the properties of the emulsions (F1) to (F3) according to the invention and the comparative emulsions (F'1) to (F'4)
[0236] 2.1 Characterization of the appearance and viscosity of the emulsions (F1) to (F3) according to the invention and the comparative emulsions (F'1) to (F'4)
[0237] The emulsions (F1) to (F3) and (F'1) to (F'4) obtained according to the above process were then stored for 3 months in an insulated climate chamber regulated at a temperature of 25° C. At the end of this three-month period, the appearance (APP) of each prepared emulsion was observed and the dynamic viscosity (μ) of each emulsion was measured (in mPas) at 25° C. by means of a viscometer (Brookfield LVT, speed 6).
[0238] Aliquots of these same emulsions (F1) to (F3) and (F'1) to (F'4) obtained according to the above process were also stored for three months in an insulated climate chamber regulated at a temperature of 45° C. At the end of this three-month period, the appearance (APP) of each prepared emulsion was observed and the dynamic viscosity (μ) of each emulsion was measured (in mPas) at 25° C. by means of a viscometer (Brookfield LVT, speed 6).
[0239] 2.2 Characterization of the orientation of the emulsions (F1) to (F3) according to the invention and the comparative emulsions (F′1) to (F′3)
[0240] After storage of the emulsion for a period of one day in an insulated climate chamber regulated at a temperature of 25° C., the emulsion was subjected to a temperature control using a thermocoupler equipped with a TetraCon TM LF 196 with 96 electrodes TM The conductivity (σ) of the emulsions (F1) to (F3) and emulsions (F'1) to (F'3) according to the present invention is measured at 25°C using a conductivity meter of the brand. For a given emulsion, (σ) ≤ 0.5 μS.cm -1 , it is believed that the emulsion is not conductive and therefore the external phase is not a 1,2-propylene glycol based or glycerol based or PEG-400 based phase but an oil phase.
[0241] In fact, the conductivity of 1,2-propylene glycol measured at 25°C is equal to 4400 μS.cm -1 , the conductivity of glycerol is 6400μS.cm -1 .
[0242] For a given emulsion, (σ)>0.5μS.cm -1 , the emulsion is considered to be conductive and therefore the external phase is considered not to be an oil phase but a glycol phase. The term "glycol phase" means a 1,2-propylene glycol-based or glycerol-based or PEG-400-based phase.
[0243] This same measurement of the conductivity of the emulsions (F1) to (F3) according to the invention and the comparative emulsions (F'1) to (F'3) was measured at 25°C after three months at 25°C and three months at 45°C.
[0244] 2.3 Results obtained for emulsions (F1) to (F3) according to the invention and comparative emulsions (F'1) to (F'3)
[0245] The evaluation methods described in sections 2.1 and 2.2 were applied to the emulsions (F1) to (F3) according to the invention and the comparative emulsions (F'1) to (F'3). The results obtained are reported in Table 2 below.
[0246] [Table 2]
[0247]
[0248] 2.4 Results Analysis
[0249] Therefore, the emulsions (F1) to (F3) according to the invention are characterized in that:
[0250] - the stability of their form of the type based on 1,2-propylene glycol dispersed in oil after storage for 3 months at a temperature of 25°C; the appearance observed after this storage period remains homogeneous;
[0251] - stability of their form of the type based on 1,2-propylene glycol dispersed in oil after storage for 3 months at a temperature of 45°C; the appearance observed after this storage period remains homogeneous;
[0252] The comparative emulsion (F'1) comprising sorbitan monooleate as oil-in-water lipophilic surfactant does not make it possible to obtain an emulsion in which the dispersed phase is a phase based on 1,2-propylene glycol.
[0253] Comparative emulsions (F'2), (F'3) and (F'4), also comprising sorbitan monooleate as oil-in-water lipophilic surfactant, make it possible to obtain emulsions in which the dispersed phase is a phase based on 1,2-propylene glycol, but a minimum amount of water is necessary.
[0254] Surprisingly, the use of the water-in-oil emulsifying surfactant sorbitan monooleate does not make it possible to obtain, without the addition of water, an emulsion in which the dispersed phase is a phase based on 1,2-propylene glycol (F'2 compared to F'1); the same is true for the use of other polyols commonly used to prepare formulations for topical application (F'3 and F'4).
Claims
1. A composition for topical use (E1) in the form of an emulsion of a dispersed phase in a continuous phase, and wherein the continuous phase is a fatty phase and the dispersed phase is polar and does not contain added water, the composition emulsion (E1) comprising, per 100% of its weight, from 60% to 90% by weight of a gelled phase (A1) which does not contain added water and is dispersed in from 10% to 40% by weight of a continuous fatty phase (A2); The gel phase (A1) comprises, per 100% by weight: - from 0.5 to 7% by weight of a crosslinked anionic polyelectrolyte (AP1); - from 93% to 99.5% by weight of at least one diol selected from 1,2-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 2,3-butylene glycol, 2,3-pentanediol, 2,3-hexanediol, 2,5-hexanediol or 2-methyl-2,4-pentanediol, and The fatty phase (A2) comprises, per 100% by weight thereof: - from 1.25% to 20% by weight of an emulsifying system, each 100% by weight of said emulsifying system comprising: - from 15 to 85% by weight of at least one emulsifying surfactant (S1) selected from the group consisting of alkyl polyglycoside compositions and compositions of alkyl polyglycosides and fatty alcohols, and - from 15 to 85% by weight of at least one emulsifying surfactant (S2) selected from the group consisting of polyglycerol esters, alkoxylated polyglycerol esters, polyglycol polyhydroxystearate, polyglycerol polyhydroxystearate and alkoxylated polyglycerol polyhydroxystearate; from 80 to 98.75% by weight of at least one oil and optionally at least one wax, wherein the crosslinked anionic polyelectrolyte (AP1) comprises a proportion greater than or equal to 25 mol % of monomer units derived from 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid in free acid or partially or completely salified form, The alkyl polyglycoside is a composition (C1) represented by formula (VII): R1-O-(G)xH(VII) wherein x represents a decimal between 1.05 and 2.5, G represents a glucosyl group or an α,β-D-glucopyranose group obtained by removing a hemiacetal hydroxyl group from α,β-D-glucopyranose, and R1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, the composition (C1) consists of: A mixture of compounds represented by formula (VII1), (VII2), (VII3), (VII4) and (VII5): R1-O-(G)1-H(VII1) R1-O-(G)2-H(VII2) R1-O-(G)3-H(VII3) R1-O-(G)4-H(VII4) R1-O-(G)5-H(VII5), These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5 such that: -The sum of a1+a2+a3+a4+a5 is equal to 1, and -The sum of a1+2a2+3a3+4a4+5a5 equals x.
2. The composition for topical use (E1) according to claim 1, characterized in that The diol is selected from 1,2-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, 1,2-hexanediol or 2-methyl-2,4-pentanediol.
3. Composition for topical use (E1) according to one of claims 1 to 2, characterized in that The emulsifying surfactant (S1) is composed of at least one alkyl polyglycoside composition (C1) represented by formula (VII): R1-O-(G)xH(VII) wherein x represents a decimal between 1.05 and 2.5, G represents a glucosyl group or an α,β-D-glucopyranose group obtained by removing a hemiacetal hydroxyl group from α,β-D-glucopyranose, and R1 represents a group of an element selected from the group consisting of n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl and n-behenyl, the composition (C1) consisting of a mixture of compounds represented by formulae (VII1), (VII2), (VII3), (VII4) and (VII5): R1-O-(G)1-H(VII1) R1-O-(G)2-H(VII2) R1-O-(G)3-H(VII3) R1-O-(G)4-H(VII4) R1-O-(G)5-H(VII5), These compounds are in the corresponding molar proportions a1, a2, a3, a4 and a5 such that: -The sum of a1+a2+a3+a4+a5 is equal to 1, and -The sum of a1+2a2+3a3+4a4+5a5 equals x.
4. Composition for topical use (E1) according to one of claims 1 to 3, characterized in that The composition comprises one or more auxiliary compounds chosen from the group consisting of foaming and / or detergent surfactants, thickening and / or gelling surfactants, thickeners and / or gelling agents, stabilizers, film-forming compounds, solvents and cosolvents, hydrotropes, plasticizers, emulsifiers and coemulsifiers, opacifiers, self-tanning agents, pearlescent agents, superfatting agents, sequestrants, chelating agents, antioxidants, fragrances, essential oils, preservatives, conditioning agents, deodorants, bleaching agents intended for bleaching body hair and skin, active ingredients intended to provide treatment and / or protection to the skin or hair, sunscreens, mineral fillers or pigments, particles giving visual effects or intended for encapsulating active agents, exfoliating particles, texturizing agents, optical brighteners and insect repellents.
5. The composition for topical use (E1) according to claim 4, characterized in that The composition comprises, per 100% of its weight, one or more self-tanning agents in a proportion of between 0.5% by weight and 10% by weight.
6. Use of a composition (E1) as claimed in one of claims 1 to 5 for the cosmetic treatment of the skin, the hair, the scalp and / or the lips.
7. Non-therapeutic cosmetic use of the composition (E1) according to claim 5 for artificial tanning and / or blackening of the skin.
8. A cosmetic treatment method for artificial tanning and / or darkening of the skin, characterized in that: The cosmetic treatment method comprises at least one step of applying the composition according to claim 5 to the human skin.
Citation Information
Patent Citations
Compositions comprising santalins, santarubins for artificially coloring the skin
EP0971683A1
Water-in-oil emulsions, especially for suncare, and process for preparing them
EP1459801A2
W / o emulsion for skin care
EP1961455A1
Novel quaternary ammonium derivatives, preparation method therefor and use thereof as surfactants
WO1996000719A1
Novel oil-in-water emulsions with a high aqueous phase content, liquid consistencies and that are stable in storage
WO2014167200A1
